Trisha Suppes

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder
    Trisha Suppes
    VA Palo Alto Health Care System, 3801 Miranda Ave 151T, Palo Alto, CA 94304
    J Clin Psychiatry 75:77-84. 2014
  2. doi request reprint First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo
    Trisha Suppes
    Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, CA, USA
    J Affect Disord 150:37-43. 2013
  3. doi request reprint Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)
    Trisha Suppes
    3801 Miranda Ave 151 T, Palo Alto, CA 94304, USA
    Am J Psychiatry 166:476-88. 2009
  4. doi request reprint Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
    Trisha Suppes
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA
    J Affect Disord 121:106-15. 2010
  5. doi request reprint Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder
    Robert M Post
    Department of Psychiatry and Behavioral Sciences, George Washington University, Washington, DC, USA
    J Clin Psychiatry 71:1176-86; quiz 1252-3. 2010
  6. ncbi request reprint Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study
    Lori L Altshuler
    Department of Psychiatry, Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles, CA, USA
    J Clin Psychiatry 70:450-7. 2009
  7. doi request reprint Co-occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: a case series
    Natalie S Feldman
    VA Palo Alto Health Care System, Palo Alto, CA, USA
    J Clin Psychiatry 73:874-7. 2012
  8. ncbi request reprint Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study
    Lori L Altshuler
    Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, CA, USA
    J Clin Psychiatry 67:1551-60. 2006
  9. doi request reprint Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis
    Alan C Swann
    Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, USA
    Am J Psychiatry 170:31-42. 2013
  10. pmc Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia
    Victoria E Cosgrove
    Bipolar and Depression Research Program, VA Palo Alto Health Care System, 3801 Miranda Avenue 151T, Palo Alto, CA 94304, USA
    BMC Med 11:127. 2013

Detail Information

Publications13

  1. ncbi request reprint A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder
    Trisha Suppes
    VA Palo Alto Health Care System, 3801 Miranda Ave 151T, Palo Alto, CA 94304
    J Clin Psychiatry 75:77-84. 2014
    ..Evidence suggests that second-generation antipsychotics (SGAs) may be useful in treating both conditions. This study examined the efficacy of ziprasidone in the treatment of these disorders...
  2. doi request reprint First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo
    Trisha Suppes
    Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, CA, USA
    J Affect Disord 150:37-43. 2013
    ....
  3. doi request reprint Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)
    Trisha Suppes
    3801 Miranda Ave 151 T, Palo Alto, CA 94304, USA
    Am J Psychiatry 166:476-88. 2009
    ..The authors evaluated the efficacy and safety of quetiapine plus lithium or divalproex in the prevention of recurrent mood events in patients with stabilized bipolar I disorder...
  4. doi request reprint Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
    Trisha Suppes
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA
    J Affect Disord 121:106-15. 2010
    ..To evaluate the effectiveness of quetiapine extended release once daily in bipolar depression...
  5. doi request reprint Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder
    Robert M Post
    Department of Psychiatry and Behavioral Sciences, George Washington University, Washington, DC, USA
    J Clin Psychiatry 71:1176-86; quiz 1252-3. 2010
    ..To evaluate the clinical correlates of and types of naturalistic treatments associated with sustained improvement/remission for at least 6 months in outpatients with bipolar disorder...
  6. ncbi request reprint Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study
    Lori L Altshuler
    Department of Psychiatry, Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles, CA, USA
    J Clin Psychiatry 70:450-7. 2009
    ..To assess long-term outcome in bipolar disorder, subjects were prospectively followed after receiving acute treatment for bipolar depression...
  7. doi request reprint Co-occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: a case series
    Natalie S Feldman
    VA Palo Alto Health Care System, Palo Alto, CA, USA
    J Clin Psychiatry 73:874-7. 2012
    ..This case series examined reports of co-occurring medical conditions with bipolar disorder in potential clinical study participants, and in particular the percentage of these individuals who were previously unaware of their conditions...
  8. ncbi request reprint Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study
    Lori L Altshuler
    Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, CA, USA
    J Clin Psychiatry 67:1551-60. 2006
    ..Research examining this relationship in persons with bipolar disorder is rare. This study sought to evaluate the association between subsyndromal depressive symptoms and role functioning in subjects with bipolar disorder...
  9. doi request reprint Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis
    Alan C Swann
    Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, USA
    Am J Psychiatry 170:31-42. 2013
    ..However, definitions of mixed states, especially those with prominent depression, are not well established...
  10. pmc Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia
    Victoria E Cosgrove
    Bipolar and Depression Research Program, VA Palo Alto Health Care System, 3801 Miranda Avenue 151T, Palo Alto, CA 94304, USA
    BMC Med 11:127. 2013
    ..Evidence from genetics, neuroscience, and pharmacotherapeutics informed the DSM-5 development process. The following discussion will emphasize some of the key factors at the forefront of the debate...
  11. ncbi request reprint Reproductive function and risk for PCOS in women treated for bipolar disorder
    Natalie L Rasgon
    Department of Psychiatry, Stanford School of Medicine, Palo Alto, CA, USA
    Bipolar Disord 7:246-59. 2005
    ..This study examined the reproductive function and prevalence of polycystic ovary syndrome (PCOS) in women with bipolar disorder taking antimanic medications...
  12. ncbi request reprint Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials
    Trisha Suppes
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California Bipolar and Depression Research Program, VA Palo Alto Health Care System, Palo Alto, California
    Depress Anxiety 30:1089-98. 2013
    ..In this pooled analysis of two similar long-term studies (D1447C00126 [NCT00107731] and D1447C00127 [NCT00081380]), lithium and divalproex treatment groups were analyzed separately...
  13. ncbi request reprint Presentation and prevalence of PTSD in a bipolar disorder population: a STEP-BD examination
    JULIA M HERNANDEZ
    Palo Alto University, Palo Alto, CA 94404, United States
    J Affect Disord 150:450-5. 2013
    ..Although rates of trauma and PTSD are higher in those with bipolar disorder than in the general population, little is known about differences across bipolar subtypes...

Research Grants7

  1. Divalproex and Placebo, Lithium, or Quetiapine for Mania
    PATRICIA SUPPES; Fiscal Year: 2007
    ..abstract_text> ..
  2. Bipolar II Depression: Lithium, SSRI, or the Combination
    Trisha Suppes; Fiscal Year: 2009
    ..We also hypothesize that the frequency of side effects will be significantly less in patients on SSRI monotherapy. Thus, secondary aims include assessment of patient satisfaction, which may affect compliance in the clinical setting. ..
  3. Divalproex and Placebo, Lithium, or Quetiapine for Mania
    PATRICIA SUPPES; Fiscal Year: 2004
    ..abstract_text> ..
  4. Divalproex and Placebo, Lithium, or Quetiapine for Mania
    PATRICIA SUPPES; Fiscal Year: 2005
    ..abstract_text> ..
  5. Divalproex and Placebo, Lithium, or Quetiapine for Mania
    PATRICIA SUPPES; Fiscal Year: 2006
    ..abstract_text> ..
  6. Bipolar II Depression: Lithium, SSRI, or the Combination
    PATRICIA SUPPES; Fiscal Year: 2006
    ..We also hypothesize that the frequency of side effects will be significantly less in patients on SSRI monotherapy. Thus, secondary aims include assessment of patient satisfaction, which may affect compliance in the clinical setting. ..
  7. Bipolar II Depression: Lithium, SSRI, or the Combination
    Trisha Suppes; Fiscal Year: 2010
    ..We also hypothesize that the frequency of side effects will be significantly less in patients on SSRI monotherapy. Thus, secondary aims include assessment of patient satisfaction, which may affect compliance in the clinical setting. ..